Last reviewed · How we verify

Angelica Sinensis — Competitive Intelligence Brief

Angelica Sinensis (Angelica Sinensis) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Herbal/Traditional Medicine.

marketed Herbal/Traditional Medicine Small molecule Live · refreshed every 30 min

Target snapshot

Angelica Sinensis (Angelica Sinensis) — London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's. Angelica sinensis (Chinese angelica root) contains bioactive compounds that promote blood circulation, reduce inflammation, and modulate immune function.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Angelica Sinensis TARGET Angelica Sinensis London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's marketed

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Angelica Sinensis — Competitive Intelligence Brief. https://druglandscape.com/ci/angelica-sinensis. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: